EGFR and medical procedure: The structural, dynamic and electrostatically-driven specificity signature of the high affinity JD1 TCR resembles the specificity signature of anti-EGFR antibodies that differentially recognize the EGFRS468R mutation that was clinically associated with acquired cetuximab resistance in colorectal cancers41.